StayCurrentMD · Update Course Rewind: DVT Prophylaxis 2024
Follow
Video·Published Dec 2024

Update Course Rewind: DVT Prophylaxis 2024

hosted by Dr. Lizzie Lee
Part of DVT 6 items
Try
Intelligent Search· scoped to deep vein thrombosis · not medical adviceSearch the whole library →
What the experts said4 expert statements · 11 host summaries
Some hospitals have rewritten protocols so the trauma surgeon, not neurosurgery, decides whether to give DVT prophylaxis
Clinical
DVT prophylaxis can be given in solid organ injuries once the patient is stable
Clinical
Patients with unstable head injury who may need ICP monitor or craniotomy should probably not receive DVT prophylaxis
Clinical
Aspirin compliance at home is likely better than enoxaparin injections
Opinion
Chemical DVT prophylaxis within 24 hours of injury reduces DVT risk in trauma patients compared to later initiation
Host summaryThe host summarizing the discussion · not cited in answers
A recent cohort study showed chemical VTE prophylaxis was safe, did not cause bleeding complications, and should be done within 24 hours to prevent VTE
Host summaryThe host summarizing the discussion · not cited in answers
Pediatric trauma patients with low bleeding risk and stable head, pelvic, or solid organ injuries should receive chemical VTE prophylaxis
Host summaryThe host summarizing the discussion · not cited in answers
Patients with continued bleeding and unstable injuries should not receive chemical VTE prophylaxis
Host summaryThe host summarizing the discussion · not cited in answers
EAST guidelines recommend prophylaxis for adolescent patients with ISS greater than 25
Host summaryThe host summarizing the discussion · not cited in answers
ISS (injury severity score) is calculated based on the worst injury of six body systems
Host summaryThe host summarizing the discussion · not cited in answers
If ISS is less than 25 or patient has major bleeding risk, avoid DVT prophylaxis
Host summaryThe host summarizing the discussion · not cited in answers
A 2023 NEJM randomized controlled trial by the Major Extremity Trauma Research Consortium included 6,000 adults on aspirin and 6,000 on enoxaparin with orthopedic injuries
Host summaryThe host summarizing the discussion · not cited in answers
In the 2023 NEJM trial, aspirin was non-inferior to enoxaparin for DVT prophylaxis in adult orthopedic trauma patients
Host summaryThe host summarizing the discussion · not cited in answers
Pediatric trauma surgeons are applying the adult aspirin non-inferiority data to pediatric patients and discharging them on aspirin
Host summaryThe host summarizing the discussion · not cited in answers
Cincinnati Children's has started discharging pediatric trauma patients on aspirin, recognizing the adult data is not perfect but aspirin is effective and better than enoxaparin or nothing
Host summaryLizzie Lee summarizing the discussion · not cited in answers